Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapy
Christine M. Liu,Ethan J. Han,Jakob L. Fischer,Jess C. Mace,Jose L. Mattos,Karolin Markarian,Jeremiah A. Alt,Todd E. Bodner,Naweed I. Chowdhury,Patricia H. Eshaghian,Anne E. Getz,Peter H. Hwang,Ashoke Khanwalkar,Adam J. Kimple,Jivianne T. Lee,Douglas A. Li,Meghan Norris,Jayakar V. Nayak,Cameran Owens,Zara M. Patel,Katie Poch,Rodney J. Schlosser,Kristine A. Smith,Timothy L. Smith,Zachary M. Soler,Jeffrey D. Suh,Grant A. Turner,Marilene B. Wang,Jennifer L. Taylor‐Cousar,Milene T. Saavedra,Daniel M. Beswick
DOI: https://doi.org/10.1002/alr.23332
2024-02-13
International Forum of Allergy & Rhinology
Abstract:Background Chronic rhinosinusitis (CRS) is common in people with cystic fibrosis (PwCF). Rhinologic symptom prioritization and areas that influence CRS treatment choices, including pursuing endoscopic sinus surgery (ESS), remain understudied. Methods Adult PwCF + CRS were enrolled at eight centers into a prospective, observational study (2019–2023). Participants were administered the 22‐SinoNasal Outcome Test (SNOT‐22) survey and a modified SNOT‐22 instrument examining symptom importance. We determined importance rankings for individual symptoms and SNOT‐22 symptom importance subdomains in two sets of subgroups—those pursuing ESS versus continuing medical management (CMT), and those on elexacaftor/tezacaftor/ivacaftor (ETI) versus not on ETI. Results Among 69 participants, the highest priorities were nasal congestion (n = 48, 69.6% important), post‐nasal discharge (32, 46.4%), facial pain (29, 43.3%), waking up tired (27, 39.1%), and fatigue (26, 37.7%). Those electing surgery (n = 23) prioritized sleep and psychological dysfunction symptoms compared to those pursuing CMT (n = 49) (sleep median score = 19.0 [interquartile range: 12.0, 25.0] vs. 4.5 [0.0, 12.8]; p
otorhinolaryngology